1-12 of 12
A. Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated Adult T-Cell Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma

Yasmin Abaza, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Deborah A Thomas, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Jan Burger, MD PhD, William G. Wierda, MD PhD, Nitin Jain, MD, Stefan Faderl, MD, Susan M. O'Brien, MD, Marina Konopleva, MD PhD, Alessandra Ferrajoli, MD, Steven M Kornblau, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Philip A Thompson, MBBS, Mary A. Kelly, Rebecca Garris, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Farhad Ravandi, MD
Journal: Blood
Blood (2016) 128 (22): 177.
https://doi.org/10.1182/blood.V128.22.177.177
Published: 2016
Journal Articles

Results Of The DFCI ALL Consortium Protocol 05-001 For Children and Adolescents With Newly Diagnosed ALL

Lewis B. Silverman, MD, Kristen E. Stevenson, MS, Uma H. Athale, M.D., M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Kara A. Kelly, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy L Schwartz, MD, MPH, Barbara Asselin, MD, Jeffrey G Supko, PhD, Sarah Hunt, MPH, Place Andrew, MD, PhD, Lynda M. Vrooman, MD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD
Journal: Blood
Blood (2013) 122 (21): 838.
https://doi.org/10.1182/blood.V122.21.838.838
Published: 2013
Journal Articles

Mobilization and Elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) Stem/Progenitor Cells by Plerixafor/G-CSF/Sorafenib: Results From a Phase I Trial in Relapsed/Refractory AML Patients

Michael Andreeff, MD, PhD, Zhihong Zeng, PhD, Mary A Kelly, RN, Rui-yu Wang, MD, PhD, Teresa McQueen, BS, Seshagiri Duvvuri, Gul Nowshad, Gautam Borthakur, MD, Jan A. Burger, MD, PhD, Tapan M. Kadia, M.D., Elias Jabbour, MD, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD, Marina Konopleva, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 142.
https://doi.org/10.1182/blood.V120.21.142.142
Published: 2012
Journal Articles

Familial and Acquired SH2B3 mutations in ALL

Arianne Perez-Garcia, PhD, Charles A. LeDuc, PhD, Kara A. Kelly, MD, Chaim Jalas, Wendy K Chung, MD, PhD, Adolfo A. Ferrando, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1326.
https://doi.org/10.1182/blood.V120.21.1326.1326
Published: 2012
Journal Articles

Phase II Study of Nelarabine with Hyper-CVAD in Patients with Previously Untreated T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (LL)

Preetesh Jain, MD, DM, PhD, Hagop M. Kantarjian, MD, Deborah A. Thomas, MD, Farhad Ravandi, MD, Tapan M. Kadia, M.D., Jan A. Burger, MD, PhD, Gautam Borthakur, M.D., Jorge E. Cortes, MD, Naval Daver, MD, Elias J. Jabbour, MD, Charles Asa Koller, Marina Konopleva, MD, PhD, Naveen Pemmaraju, M.D., Marry A Kelly, Rebecca Garris, BSc, Susan O'Brien, Stefan Faderl, MD
Journal: Blood
Blood (2012) 120 (21): 1501.
https://doi.org/10.1182/blood.V120.21.1501.1501
Published: 2012
Journal Articles

Phase II Study of the Histone Deacetylase Inhibitor Panabinostat (LBH589) in Patients with Low or Intermediate-1 Risk Myelodysplastic syndrome

Sophie Dimicoli, MD, PhD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Zeev Estrov, Hui Yang, MD, PhD, Mary A Kelly, RN, Sherry Pierce, RN, BS, Hagop M. Kantarjian, Guillermo Garcia-Manero
Journal: Blood
Blood (2011) 118 (21): 1731.
https://doi.org/10.1182/blood.V118.21.1731.1731
Published: 2011
Journal Articles

A Stat5b transgene is capable of inducing CD8 + lymphoblastic lymphoma in the absence of normal TCR/MHC signaling

Katherine Bessette, Mark L. Lang, Roy A. Fava, Martin Grundy, Jennifer Heinen, Laurie Horne, Rosanne Spolski, Amin Al-Shami, Herbert C. Morse, III, Warren J. Leonard, John A. Kelly
Journal: Blood
Blood (2008) 111 (1): 344–350.
https://doi.org/10.1182/blood-2007-04-084707
Published: 2008
Includes: Supplemental data
Journal Articles

A Dose Escalation Study of the Pharmacokinetics, Safety & Efficacy of Deferitrin, an Oral Iron Chelator in Beta Thalassaemia Patients.

R. Galanello, G. Forni, A. Jones, A. Kelly, A. Willemsen, X. He, A. Johnston, D. Fuller, J. Donovan, Antonio Piga
Journal: Blood
Blood (2007) 110 (11): 2669.
https://doi.org/10.1182/blood.V110.11.2669.2669
Published: 2007
Journal Articles

Human Pharmacokinetics of AC220, a Potent and Selective Class III Receptor Tyrosine Kinase Inhibitor.

Jorge Cortes, James M. Foran, Marcel P. Devetten, Francis J. Giles, Joyce James, Patrick P. Zarrinkar, Michael H. Silverman, Kerry A. Kelly, Norman M. Padre, Shripad Bhagwat, Wendell Wierenga
Journal: Blood
Blood (2007) 110 (11): 1597.
https://doi.org/10.1182/blood.V110.11.1597.1597
Published: 2007
Journal Articles

GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients.

Robert J. Tressler, PhD, Allison C. Chin, Ph.D., Eric J. Feldman, M.D., Kanti R. Rai, M.D., Doug Kornbrust, Ph.D., Calvin B. Harley, Ph.D., Melissa A. Kelly Behrs, Laurence Elias, MD
Journal: Blood
Blood (2006) 108 (11): 2595.
https://doi.org/10.1182/blood.V108.11.2595.2595
Published: 2006
Journal Articles

Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13

R. Hal Scofield, Gail R. Bruner, Jennifer A. Kelly, Jeff Kilpatrick, Debra Bacino, Swapan K. Nath, John B. Harley
Journal: Blood
Blood (2003) 101 (3): 992–997.
https://doi.org/10.1182/blood-2002-04-1003
Published: 2003
Journal Articles

Human Follicular Dendritic Cells Inhibit Superantigen-Induced T-Cell Proliferation by Distinct Mechanisms

Anthony W. Butch, Kathleen A. Kelly, Michael S. Willbanks, Xinwen Yu
Journal: Blood
Blood (1999) 94 (1): 216–224.
https://doi.org/10.1182/blood.V94.1.216.413k34_216_224
Published: 1999